HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women

Background: Breast cancer in very young women (BCVY) defined as <35 years old, presents with different molecular biology than in older patients. High HDAC5 expression has been associated with poor prognosis in breast cancer (BC) tissue. We aimed to analyze HDAC5 expression in BCVY and older patie...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancers (Basel)
Auteurs principaux: Oltra, Sara S., Cejalvo, Juan Miguel, Tormo, Eduardo, Albanell, Marta, Ferrer, Ana, Nacher, Marta, Bermejo, Begoña, Hernando, Cristina, Chirivella, Isabel, Alonso, Elisa, Burgués, Octavio, Peña-Chilet, Maria, Eroles, Pilar, Lluch, Ana, Ribas, Gloria, Martinez, María Teresa
Format: Artigo
Langue:Inglês
Publié: MDPI 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7072585/
https://ncbi.nlm.nih.gov/pubmed/32050699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12020412
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires